AS

Antima Singh

Active Director Director DIN 10454807
DIN 10454807 First appointment Jan 2024 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jan 2024
Shareholding value Locked Premium profile

About Antima Singh

Data last updated:

Antima Singh has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Zipka Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10454807
Primary Designation Director
First Appointment 04 Jan 2024
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Director04 Jan 20242022Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zipka Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Antima Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Antima Singh

Antima Singh has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Zipka Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Antima Singh is associated with 1 company as Director.

Antima Singh has expertise in General Business.

Antima Singh has 2 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available